Found 37 dm-pulmonary-allergy-and-critical-care trials
A listing of dm-pulmonary-allergy-and-critical-care medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The purpose of this study is to collect clinical data, blood samples (including DNA), and PROs in 2,600 lung transplant candidates, donors, and recipients across the participating LTC centers to create a resource that will support a broad range of future clinical and research objectives. The data collected will support …
This study will look at the efficacy, safety, and tolerability of itepekimab, in people with non-cystic fibrosis bronchiectasis. Patients will be asked to complete a CT, lab tests, safety labs, lung function tests, PEs, ECGs, and questionnaires.
To evaluate if use of the Percepta Nasal Swab test in the diagnostic work up of newly identified pulmonary nodules reduces the number of invasive procedures in the group classified as low-risk by the test and that are benign as compared to a control group managed without a Percepta Nasal …
Reliance Agreement requested with VUMC (IREx). Creation of an observational phenotyping cohort of patients with acute respiratory distress syndrome, pneumonia or sepsis. Clinical risk factors, molecular phenotypes, and illness trajectories during the acute and recovery phases of these critical illness syndromes to be assessed. Alteration protocol describes the minimal risk …
Reliance Agreement requested with VUMC (IREx). Creation of an observational phenotyping cohort of patients with acute respiratory distress syndrome, pneumonia or sepsis. Clinical risk factors, molecular phenotypes, and illness trajectories during the acute and recovery phases of these critical illness syndromes to be assessed. Full study protocol (Protocol A) describes …
The research study is being conducted to better understand how fat and muscle are related to disability and health-related quality of life in people with idiopathic pulmonary fibrosis.
The aim of the pilot study is to demonstrate feasibility and tolerability of semaglutide in patients with obesity and advanced ILD.
